Home > Products > API > Sofosbuvir
Sofosbuvir
  • SofosbuvirSofosbuvir

Sofosbuvir

Product Name: Sofosbuvir
Formulae hypotheticae: C22H29FN3O9P
M. Pondus; 529.45
CAS Subcriptio Number: 1190307-88-0

Model:CAS NO:1190307-88-0

Mitte Inquisitionem

depictio producti

Sofosbuvir

Product nomen:Sofosbuvir 1190307-88-0
CAS No:1190307-88-0
Specification: in domo

Nomen Sofosbuvir
Synonyma (S)-isopropyl2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)-4-fluoro -3-hydroxy-4-Methyltetrahydrofuran-2-yl)Methoxy)(phenoxy )phosphoryl)aMino)propanoate;PSI-7977 Discontinued;L-Alanine,N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-Methyl-P-phenyl-5' -uridylyl]-,1-MethylethylChemic albookester;SophyBouvet;Sofosbuvirandintermedia;Sofosbuvir1190307-88-0; Isopropyl(2S)-2-{[(S)-{[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4- dihydro-1(2H)-py rimidinyl) -4-fluoro-3-hydroxy-4-methyltetrahydro-2-furanyl]methoxy}(phenoxy)phosphoryl]amino}propanoate;PSI-7977;GS-7977;PSI7977;GS7977;SOFOSBUVIR
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C22H29FN3O9P
M. Pondus 529.45
CAS Subcriptio Number 1190307-88-0


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Sofosbuvir, China, Suppliers, Fabrica, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept